{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:41:43Z","timestamp":1789746103526,"version":"4.0.1"},"reference-count":79,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Approximately 5\u201310% of cutaneous melanoma occurs in individuals with a family history of the disease. While known high-penetrance genes, such as CDKN2A, explain some cases, a substantial proportion of hereditary melanoma remains genetically undefined. Recently, germline variants in genes involved in telomere regulation, including POT1, TERT, ACD, and TERF2IP, have been identified in melanoma-prone families. This study investigated the prevalence and pathogenicity of POT1 variants in a Swedish familial melanoma cohort.\nPatient\/material and methods: A total of 168 familial melanoma cases were screened for CDKN2A, CDK4, BAP1, and POT1. The population frequency of pathogenic variants (PVs) was assessed using the SweGen and the gnomAD databases. Functional evaluation was performed using a saturation genome editing (SGE) assay. Telomere length analysis was performed using quantitative polymerase chain reaction (qPCR) on blood-derived DNA from melanoma patients and healthy controls. The melanomas of the carriers were reviewed by expert dermatopathologists.\nResults: Among the 161 CDKN2A\/CDK4\/BAP1-negative melanoma families included in this cohort, only one likely PV in POT1 (c.676C &gt; A, p.His226Asn) was identified (0.6%). Population data confirmed its rarity. The carrier family exhibited multiple early-onset melanomas, with two out of three invasive cases displaying spitzoid morphology, and several other tumors. No significant telomere length differences were observed between carriers and controls. Two additional POT1 variants of uncertain significance were detected; both were predicted to be benign.\nInterpretation: POT1 PVs were rare in the studied Swedish familial melanoma cases, implying limited contribution to hereditary melanoma in this population. Nonetheless, the identification of a previously unknown likely PV further supports the need for continued genetic screening in selected cases. POT1 testing should be considered in families with multiple melanomas, early onset and spitzoid histopathology, and co-occurring with other syndromic tumors.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.44048","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:54:53Z","timestamp":1756108493000},"page":"1102-1108","source":"Crossref","is-referenced-by-count":2,"title":["POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1039-2873","authenticated-orcid":false,"given":"Konstantinos","family":"Papadakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-2357","authenticated-orcid":false,"given":"Francesca","family":"Portelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-1289","authenticated-orcid":false,"given":"Karina","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Olsson Sterky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismini","family":"Vassilaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-8959","authenticated-orcid":false,"given":"Jan","family":"Lapins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-2522","authenticated-orcid":false,"given":"Michael R.","family":"Sargen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6709-7332","authenticated-orcid":false,"given":"Sofia","family":"Obolenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-0306","authenticated-orcid":false,"given":"David J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-5667","authenticated-orcid":false,"given":"Veronica","family":"H\u00f6iom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0735-4771","authenticated-orcid":false,"given":"Hildur","family":"Helgadottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"124025","doi-asserted-by":"crossref","unstructured":"Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44(2):99\u2013106.","DOI":"10.1136\/jmg.2006.043802"},{"key":"124026","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/jmg.2006.043802","DOI":"10.1136\/jmg.2006.043802"},{"key":"124027","doi-asserted-by":"crossref","unstructured":"Pissa M, Helkkula T, Appelqvist F, Silander G, Borg \u00c5, Pettersson J, et al. CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015\u20132020: implications for novel national recommendations. Acta Oncol. 2021;60(7):888\u201396.","DOI":"10.1080\/0284186X.2021.1914346"},{"key":"124028","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2021.1914346","DOI":"10.1080\/0284186X.2021.1914346"},{"key":"124029","doi-asserted-by":"crossref","unstructured":"Helgadottir H, H\u00f6iom V, Tuominen R, Nielsen K, J\u00f6nsson G, Olsson H, et al. Germline CDKN2A mutation status and survival in familial melanoma cases. J Natl Cancer Inst. 2016;108(11):djw135.","DOI":"10.1093\/jnci\/djw135"},{"key":"124030","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jnci\/djw135","DOI":"10.1093\/jnci\/djw135"},{"key":"124031","doi-asserted-by":"crossref","unstructured":"Helgadottir H, Schultz K, Lapins J, Vassilaki I, All-Eriksson C, H\u00f6iom V. BAP1 genetic testing among melanoma and cancer-prone families in Sweden. Acta Oncol. 2023;62(6):565\u201370.","DOI":"10.1080\/0284186X.2023.2216338"},{"key":"124032","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2023.2216338","DOI":"10.1080\/0284186X.2023.2216338"},{"key":"124033","doi-asserted-by":"crossref","unstructured":"Shi J, Yang XR, Ballew B, Rotunno M, Calista D, Fargnoli MC, et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet. 2014;46(5):482\u20136.","DOI":"10.1038\/ng.2941"},{"key":"124034","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/ng.2941","DOI":"10.1038\/ng.2941"},{"key":"124035","doi-asserted-by":"crossref","unstructured":"Robles-Espinoza CD, Harland M, Ramsay AJ, Aoude LG, Quesada V, Ding Z, et al. POT1 loss-of-function variants predispose to familial melanoma. Nat Genet. 2014;46(5):478\u201381.","DOI":"10.1038\/ng.2947"},{"key":"124036","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/ng.2947","DOI":"10.1038\/ng.2947"},{"key":"124037","doi-asserted-by":"crossref","unstructured":"Aoude LG, Pritchard AL, Robles-Espinoza CD, Wadt K, Harland M, Choi J, et al. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. J Natl Cancer Inst. 2015;107(2):dju408.","DOI":"10.1093\/jnci\/dju408"},{"key":"124038","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jnci\/dju408","DOI":"10.1093\/jnci\/dju408"},{"key":"124039","doi-asserted-by":"crossref","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, et al. TERT promoter mutations in familial and sporadic melanoma. Science. 2013;339(6122):959\u201361.","DOI":"10.1126\/science.1230062"},{"key":"124040","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1126\/science.1230062","DOI":"10.1126\/science.1230062"},{"key":"124041","doi-asserted-by":"crossref","unstructured":"Potrony M, Puig-Butille JA, Ribera-Sola M, Iyer V, Robles-Espinoza CD, Aguilera P, et al. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families. Br J Dermatol. 2019;181(1):105\u201313.","DOI":"10.1111\/bjd.17443"},{"key":"124042","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.17443","DOI":"10.1111\/bjd.17443"},{"key":"124043","doi-asserted-by":"crossref","unstructured":"Greider CW, Blackburn EH. Identification of a specific telomere \u00adterminal transferase activity in Tetrahymena extracts. Cell. 1985;43(2 Pt 1):405\u201313.","DOI":"10.1016\/0092-8674(85)90170-9"},{"key":"124044","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/0092-8674(85)90170-9","DOI":"10.1016\/0092-8674(85)90170-9"},{"key":"124045","doi-asserted-by":"crossref","unstructured":"Potjer TP, Bollen S, Grimbergen AJEM, van Doorn R, Gruis NA, van Asperen CJ, et al. Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A\/CDK4 melanoma families. Int J Cancer. 2019;144(10):2453\u201364.","DOI":"10.1002\/ijc.31984"},{"key":"124046","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ijc.31984","DOI":"10.1002\/ijc.31984"},{"key":"124047","doi-asserted-by":"crossref","unstructured":"M\u00fcller C, Krunic M, Wendt J, von Haeseler A, Okamoto I. Germline variants in the POT1-gene in high-risk melanoma patients in Austria. G3 (Bethesda). 2018;8(5):1475\u201380.","DOI":"10.1534\/g3.117.300394"},{"key":"124048","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1534\/g3.117.300394","DOI":"10.1534\/g3.117.300394"},{"key":"124049","doi-asserted-by":"crossref","unstructured":"Baur JA, Zou Y, Shay JW, Wright WE. Telomere position effect in human cells. Science. 2001;292(5524):2075\u20137.","DOI":"10.1126\/science.1062329"},{"key":"124050","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1126\/science.1062329","DOI":"10.1126\/science.1062329"},{"key":"124051","doi-asserted-by":"crossref","unstructured":"de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19(18):2100\u201310.","DOI":"10.1101\/gad.1346005"},{"key":"124052","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1101\/gad.1346005","DOI":"10.1101\/gad.1346005"},{"key":"124053","doi-asserted-by":"crossref","unstructured":"Simonin-Wilmer I, Ossio R, Leddin EM, Harland M, Pooley KA, Martil de la Garza MG, et al. Population-based analysis of. J Med Genet. 2023;60(7):692\u20136.","DOI":"10.1136\/jmg-2022-108776"},{"key":"124054","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/jmg-2022-108776","DOI":"10.1136\/jmg-2022-108776"},{"key":"124055","doi-asserted-by":"crossref","unstructured":"Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Doddapaneni H, et al. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst. 2015;107(1):384.","DOI":"10.1093\/jnci\/dju384"},{"key":"124056","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jnci\/dju384","DOI":"10.1093\/jnci\/dju384"},{"key":"124057","doi-asserted-by":"crossref","unstructured":"Speedy HE, Kinnersley B, Chubb D, Broderick P, Law PJ, Litchfield K, et al. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia. Blood. 2016;128(19):2319\u201326.","DOI":"10.1182\/blood-2016-01-695692"},{"key":"124058","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1182\/blood-2016-01-695692","DOI":"10.1182\/blood-2016-01-695692"},{"key":"124059","doi-asserted-by":"crossref","unstructured":"Lim TL, Lieberman DB, Davis AR, Loren AW, Hausler R, Bigdeli A, et al. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms. Leukemia. 2022;36(1):283\u20137.","DOI":"10.1038\/s41375-021-01335-w"},{"key":"124060","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41375-021-01335-w","DOI":"10.1038\/s41375-021-01335-w"},{"key":"124061","doi-asserted-by":"crossref","unstructured":"Chubb D, Broderick P, Dobbins SE, Frampton M, Kinnersley B, Penegar S, et al. Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. Nat Commun. 2016;7:11883.","DOI":"10.1038\/ncomms11883"},{"key":"124062","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/ncomms11883","DOI":"10.1038\/ncomms11883"},{"key":"124063","doi-asserted-by":"crossref","unstructured":"Calvete O, Garcia-Pavia P, Dom\u00ednguez F, Bougeard G, Kunze K, Braeuninger A, et al. The wide spectrum of POT1 gene variants correlates with multiple cancer types. Eur J Hum Genet. 2017;25(11):1278\u201381.","DOI":"10.1038\/ejhg.2017.134"},{"key":"124064","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/ejhg.2017.134","DOI":"10.1038\/ejhg.2017.134"},{"key":"124065","doi-asserted-by":"crossref","unstructured":"Calvete O, Martinez P, Garcia-Pavia P, Benitez-Buelga C, Paumard-Hern\u00e1ndez B, Fernandez V, et al. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families. Nat Commun. 2015;6:8383.","DOI":"10.1038\/ncomms9383"},{"key":"124066","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/ncomms9383","DOI":"10.1038\/ncomms9383"},{"key":"124067","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","DOI":"10.1038\/gim.2015.30"},{"key":"124068","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/gim.2015.30","DOI":"10.1038\/gim.2015.30"},{"key":"124069","doi-asserted-by":"crossref","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062\u2013D7.","DOI":"10.1093\/nar\/gkx1153"},{"key":"124070","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/nar\/gkx1153","DOI":"10.1093\/nar\/gkx1153"},{"key":"124071","doi-asserted-by":"crossref","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978\u201380.","DOI":"10.1093\/bioinformatics\/bty897"},{"key":"124072","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/bioinformatics\/bty897","DOI":"10.1093\/bioinformatics\/bty897"},{"key":"124073","doi-asserted-by":"crossref","unstructured":"Obolenski S, Olvera-Le\u00f3n R, Sun D, Adams DJ, Waters AJ. Protocol for the functional evaluation of genetic variants using saturation genome editing. STAR Protoc. 2025;6(2):103710.","DOI":"10.1016\/j.xpro.2025.103710"},{"key":"124074","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.xpro.2025.103710","DOI":"10.1016\/j.xpro.2025.103710"},{"key":"124075","doi-asserted-by":"crossref","unstructured":"Ameur A, Dahlberg J, Olason P, Vezzi F, Karlsson R, Martin M, et al. SweGen: a whole-genome data resource of genetic variability in a cross-section of the Swedish population. Eur J Hum Genet. 2017;25(11):1253\u201360.","DOI":"10.1038\/ejhg.2017.130"},{"key":"124076","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/ejhg.2017.130","DOI":"10.1038\/ejhg.2017.130"},{"key":"124077","doi-asserted-by":"crossref","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","DOI":"10.1530\/ey.17.14.3"},{"key":"124078","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1530\/ey.17.14.3","DOI":"10.1530\/ey.17.14.3"},{"key":"124079","doi-asserted-by":"crossref","unstructured":"Joglekar MV, Satoor SN, Wong WKM, Cheng F, Ma RCW, Hardikar AA. An optimised step-by-step protocol for measuring relative telomere length. Methods Protoc. 2020;3(2):27.","DOI":"10.3390\/mps3020027"},{"key":"124080","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/mps3020027","DOI":"10.3390\/mps3020027"},{"key":"124081","doi-asserted-by":"crossref","unstructured":"Yeh I. New and evolving concepts of melanocytic nevi and melanocytomas. Mod Pathol. 2020;33(Suppl 1):1\u201314.","DOI":"10.1038\/s41379-019-0390-x"},{"key":"124082","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41379-019-0390-x","DOI":"10.1038\/s41379-019-0390-x"},{"key":"124083","doi-asserted-by":"crossref","unstructured":"Barnhill RL. The spitzoid lesion: rethinking Spitz tumors, atypical variants, \u2018Spitzoid melanoma\u2019 and risk assessment. Mod Pathol. 2006;19(Suppl 2):S21\u201333.","DOI":"10.1038\/modpathol.3800519"},{"key":"124084","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/modpathol.3800519","DOI":"10.1038\/modpathol.3800519"},{"key":"124085","doi-asserted-by":"crossref","unstructured":"Sargen MR, Barnhill RL, Elder DE, Swetter SM, Prieto VG, Ko JS, et al. Evaluation and surgical management of pediatric cutaneous melanoma and atypical Spitz and non-Spitz melanocytic tumors (melanocytomas): a report from Children\u2019s Oncology Group. J Clin Oncol. 2025;43(9):1157\u201367.","DOI":"10.1200\/JCO.24.01154"},{"key":"124086","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.24.01154","DOI":"10.1200\/JCO.24.01154"},{"key":"124087","doi-asserted-by":"crossref","unstructured":"Sargen MR, Calista D, Elder DE, Massi D, Chu EY, Potrony M, et al. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain. J Am Acad Dermatol. 2020;83(3):860\u20139.","DOI":"10.1016\/j.jaad.2020.03.100"},{"key":"124088","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2020.03.100","DOI":"10.1016\/j.jaad.2020.03.100"},{"key":"124089","doi-asserted-by":"crossref","unstructured":"Goldstein AM, Qin R, Chu EY, Elder DE, Massi D, Adams DJ, et al. Association of germline variants in telomere maintenance genes. JAAD Int. 2023;11:43\u201351.","DOI":"10.1016\/j.jdin.2023.01.013"},{"key":"124090","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jdin.2023.01.013","DOI":"10.1016\/j.jdin.2023.01.013"},{"key":"124091","doi-asserted-by":"crossref","unstructured":"Helgadottir H, H\u00f6iom V, Tuominen R, J\u00f6nsson G, M\u00e5nsson-Brahme E, Olsson H, et al. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies. Int J Cancer. 2015;137(9):2220\u20136.","DOI":"10.1002\/ijc.29595"},{"key":"124092","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ijc.29595","DOI":"10.1002\/ijc.29595"},{"key":"124093","doi-asserted-by":"crossref","unstructured":"Abu Shtaya A, Kedar I, Bazak L, Basel-Salmon L, Barhom SF, Naftali M, et al. A. Genes (Basel). 2024;15(3):365.","DOI":"10.3390\/genes15030355"},{"key":"124094","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/genes15030355","DOI":"10.3390\/genes15030355"},{"key":"124095","doi-asserted-by":"crossref","unstructured":"Gerami P, Chen A, Sharma N, Patel P, Hagstrom M, Kancherla P, et al. BRAF mutated and morphologically spitzoid tumors, a subgroup of melanocytic neoplasms difficult to distinguish from true Spitz neoplasms. Am J Surg Pathol. 2024;48(5):538\u201345.","DOI":"10.1097\/PAS.0000000000002194"},{"key":"124096","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/PAS.0000000000002194","DOI":"10.1097\/PAS.0000000000002194"},{"key":"124097","doi-asserted-by":"crossref","unstructured":"Raghavan SS, Peternel S, Mully TW, North JP, Pincus LB, LeBoit PE, et al. Spitz melanoma is a distinct subset of spitzoid melanoma. Mod Pathol. 2020;33(6):1122\u201334.","DOI":"10.1038\/s41379-019-0445-z"},{"key":"124098","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41379-019-0445-z","DOI":"10.1038\/s41379-019-0445-z"},{"key":"124099","doi-asserted-by":"crossref","unstructured":"Helgadottir H, Olsson H, Tucker MA, Yang XR, H\u00f6iom V, Goldstein AM. Phenocopies in melanoma-prone families with germ-line CDKN2A mutations. Genet Med. 2018;20(9):1087\u201390.","DOI":"10.1038\/gim.2017.216"},{"key":"124100","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/gim.2017.216","DOI":"10.1038\/gim.2017.216"},{"key":"124101","doi-asserted-by":"crossref","unstructured":"Baptista Freitas M, Desmyter L, Badoer C, Smits G, Vandernoot I, T Kint de Roodenbeke D. POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program. Eur J Hum Genet. 2024;32(8):980\u20136.","DOI":"10.1038\/s41431-024-01611-0"},{"key":"124102","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41431-024-01611-0","DOI":"10.1038\/s41431-024-01611-0"},{"key":"124103","doi-asserted-by":"crossref","unstructured":"Tsoulaki O, Evans DG, Sinha K, Rajan N, Bakr F, Hatcher H, et al. UK clinical practice guidelines for the management of patients with constitutional. J Med Genet. 2025;62:559\u201365 https:\/\/doi.org\/10.1136\/jmg-2025-110638","DOI":"10.1136\/jmg-2025-110638"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/44048\/51152","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/44048\/51152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:04:36Z","timestamp":1756404276000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/44048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":79,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.44048","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]}}}